FSD Pharma Inc - Class B - Class B (Sub Voting) chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share N/A
Dividend & YieldN/A$ (N/A)
Beta 0.92
Market capitalization 34.03M
Operating cash flow -26.1M
ESG Scores unknown

Company description

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. is headquartered in Toronto, Canada.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 433.75k 1.52M 898.69k 3.6M
Total Cashflows From Investing Activities -9.99M -230.89k 6.51M 268.96k
Net Borrowings -42.28k -42.28k -986.64k -129.32k
Total Cash From Financing Activities 44.88M 4.01M 24.17M 38.21M
Change To Operating Activities -99.26k -24.21k -526.74k -609.15k
Issuance Of Stock 48.64M 4.05M 25.16M 38.34M
Net Income -22.71M -39.13M -31.8M -35.29M
Change In Cash 16.39M -9.93M 11.56M 17.73M
Effect Of Exchange Rate
Total Cash From Operating Activities -18.49M -13.71M -19.13M -20.75M
Depreciation 183.19k 1.94M 3.9M 4.05M
Change To Account Receivables -664.61k -387.84k 435.18k -106.88k
Other Cashflows From Financing Activities -3.77M
Change To Netincome -3.62M 22.37M 7.96M 7.6M
Capital Expenditures -4.03M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 7.83M 7.83M 7.83M 6.33M
Income Before Tax -22.71M -34.08M -28.45M -33.94M
Net Income -22.71M -39.13M -31.8M -35.29M
Selling General Administrative 17.38M 8.41M 10.06M 15.93M
Gross Profit -1.36M
Ebit -25.36M -22.43M -29.84M -33.74M
Operating Income -25.36M -22.43M -29.84M -33.74M
Interest Expense -155.32k -155.32k -235.58k -69.4k
Income Tax Expense
Total Revenue
Cost Of Revenue 1.36M
Total Other Income ExpenseNet 2.65M -11.65M 1.39M -194.3k
Net Income From Continuing Ops -22.71M -34.08M -28.45M -33.94M
Net Income Applicable To Common Shares -22.71M -39.13M -31.8M -35.29M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 1.74M 6.94M 5.66M 8.83M
Total Stockholder Equity 51.03M 36.28M 36.31M 54.13M
Other Current Liabilities 1.99M 1.46M 825.1k
Total Assets 52.78M 43.22M 41.97M 62.96M
Common Stock 68.12M 73.74M 103.21M 152.32M
Other Current Assets 8.61M 9.25M
Retained Earnings -26.5M -59.07M -90.87M -126.15M
Treasury Stock 4.44M 4.24M 5.18M 5.38M
Cash 21.13M 5.97M 17.52M 35.26M
Total Current Liabilities 1.74M 6.83M 5.58M 8.7M
Other Stockholder Equity 4.44M 4.24M 5.18M 5.38M
Property, Plant, and Equipment 12.14M 8.98M 168.31k
Total Current Assets 22.57M 8.56M 26.87M 45.93M
Net Tangible Assets 51.03M 19.46M 22.88M 37.93M
Net Receivables 990.99k 1.56M 161.34k 500.96k
Accounts Payable 1.74M 3.29M 2.06M 3M


Insider Transactions

Here are the insider transactions of stock shares related to FSD Pharma Inc - Class B - Class B (Sub Voting):

Filer Name Transaction Text Ownership Date Filer Relation Shares
Carroll (Donal)Acquisition or disposition in the public market at price 0.94 per share.D2022-09-27Director of Issuer5k
Carroll (Donal)Acquisition or disposition in the public market at price 0.93 per share.D2022-09-27Director of Issuer1k
Carroll (Donal)Acquisition or disposition in the public market at price 0.87 per share.D2022-09-26Director of Issuer3.5k
Carroll (Donal)Acquisition or disposition in the public market at price 0.86 per share.D2022-09-26Director of Issuer1k
Carroll (Donal)Acquisition or disposition in the public market at price 0.84 per share.D2022-09-26Director of Issuer1k
Carroll (Donal)Acquisition or disposition in the public market at price 0.85 per share.D2022-09-26Director of Issuer1k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.94 per share.D2022-09-26Director of Issuer20k
FSD Pharma, Inc.Redemption, retraction, cancelation, repurchase at price 0.92 per share.D2022-09-26Issuer10k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.95 per share.D2022-09-26Director of Issuer4k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.94 per share.D2022-09-26Director of Issuer3k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.94 per share.D2022-09-26Director of Issuer20k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.93 per share.D2022-09-26Director of Issuer8.4k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.94 per share.D2022-09-26Director of Issuer1.6k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.90 per share.D2022-09-26Director of Issuer15k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.86 per share.D2022-09-26Director of Issuer4.5k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.90 per share.D2022-09-26Director of Issuer500
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.99 per share.D2022-08-12Director of Issuer10k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 1.01 per share.D2022-08-12Director of Issuer6.83k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.98 per share.D2022-08-12Director of Issuer3k
Carroll (Donal)Acquisition or disposition in the public market at price 1.00 per share.D2022-08-12Director of Issuer4.16k
FSD Pharma, Inc.Redemption, retraction, cancelation, repurchase at price 0.90 per share.D2022-07-28Issuer5k
Carroll (Donal)Acquisition or disposition in the public market at price 0.99 per share.D2022-07-15Director of Issuer6k
Coyle (Nathan Patrick)Acquisition or disposition in the public market at price 0.94 per share.D2022-06-10Senior Officer of Issuer1.5k
Carroll (Donal)Acquisition or disposition in the public market at price 1.00 per share.D2022-06-08Director of Issuer3.38k
Carroll (Donal)Acquisition or disposition in the public market at price 1.00 per share.D2022-06-07Director of Issuer2.04k
Carroll (Donal)Acquisition or disposition in the public market at price 0.99 per share.D2022-06-03Director of Issuer10k
Carroll (Donal)Acquisition or disposition in the public market at price 0.99 per share.D2022-05-26Director of Issuer10k
Carroll (Donal)Acquisition or disposition in the public market at price 0.99 per share.D2022-05-26Director of Issuer500
Carroll (Donal)Acquisition or disposition in the public market at price 1.00 per share.D2022-05-26Director of Issuer9.5k
Carroll (Donal)Acquisition or disposition in the public market at price 1.02 per share.D2022-05-26Director of Issuer10k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.96 per share.I2022-05-26Director of Issuer2.9k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.99 per share.I2022-05-26Director of Issuer10k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 1.00 per share.I2022-05-26Director of Issuer10k
Carroll (Donal)Acquisition or disposition in the public market at price 0.95 per share.D2022-05-19Director of Issuer5k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.88 per share.D2022-05-17Director of Issuer8.5k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.91 per share.I2022-05-17Director of Issuer2.4k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.93 per share.I2022-05-17Director of Issuer1k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.94 per share.I2022-05-17Director of Issuer1.3k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.94 per share.I2022-05-17Director of Issuer1k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.95 per share.I2022-05-17Director of Issuer2.9k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.88 per share.D2022-05-13Director of Issuer6.67k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 0.87 per share.D2022-05-13Director of Issuer1.11k
Carroll (Donal)Acquisition or disposition in the public market at price 0.88 per share.D2022-05-13Director of Issuer3.4k
Carroll (Donal)Acquisition or disposition in the public market at price 1.00 per share.D2022-05-03Director of Issuer5k
Carroll (Donal)Acquisition or disposition in the public market at price 0.99 per share.D2022-05-03Director of Issuer5k
Carroll (Donal)Acquisition or disposition in the public market at price 0.98 per share.D2022-05-03Director of Issuer10k
Carroll (Donal)Acquisition or disposition in the public market at price 1.00 per share.D2022-04-29Director of Issuer5k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 1.01 per share.D2022-04-29Director of Issuer400
Saeed (Zeeshan)Acquisition or disposition in the public market at price 1.02 per share.D2022-04-29Director of Issuer6.5k
Saeed (Zeeshan)Acquisition or disposition in the public market at price 1.03 per share.D2022-04-29Director of Issuer8.89k
Durkacz (Anthony John)Acquisition or disposition in the public market at price 0.98 per share.D2022-04-2510% Security Holder of Issuer50k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to FSD Pharma Inc - Class B - Class B (Sub Voting). You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on FSD Pharma Inc - Class B - Class B (Sub Voting)

Here is the result of two systematic investment strategies applied to FSD Pharma Inc - Class B - Class B (Sub Voting). The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on FSD Pharma Inc - Class B - Class B (Sub Voting)

The following chart shows the equity curve of the two systematic investment strategies applied to FSD Pharma Inc - Class B - Class B (Sub Voting):

FSD Pharma Inc - Class B - Class B (Sub Voting) automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 97.59% on the backtest period.

Performance at glance

Performance

97.59 %

Latent gain

1462.95 $

Invested capital

1499.13 $

Annualized return

27.72 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on FSD Pharma Inc - Class B - Class B (Sub Voting)

This is the result of two momentum investment strategies applied to FSD Pharma Inc - Class B - Class B (Sub Voting). The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on FSD Pharma Inc - Class B - Class B (Sub Voting)

The following chart shows all the entries opened by the momentum investment system on FSD Pharma Inc - Class B - Class B (Sub Voting):

FSD Pharma Inc - Class B - Class B (Sub Voting) momentum entries
  • The first momentum investment strategy would give 456.17% of return on FSD Pharma Inc - Class B - Class B (Sub Voting). That represents 14824.16$ of latent gain with 3249.73$ of employed capital.
  • The second momentum investment strategy would give 530.04% of return on FSD Pharma Inc - Class B - Class B (Sub Voting). That represents 13241.01$ of latent gain with 2498.1$ of employed capital.
Performance at glance (1Q Momentum)

Performance

456.17 %

Latent gain

14824.16 $

Invested capital

3249.73 $

Annualized return

5.1 %
Performance at glance (2Q Momentum)

Performance

530.04 %

Latent gain

13241.01 $

Invested capital

2498.1 $

Annualized return

174.36 %

Momentum equity curve on FSD Pharma Inc - Class B - Class B (Sub Voting)

The following chart shows the equity curve of the two momentum strategies applied to FSD Pharma Inc - Class B - Class B (Sub Voting):

FSD Pharma Inc - Class B - Class B (Sub Voting) momentum equity

Note: the dividends potentially given by FSD Pharma Inc - Class B - Class B (Sub Voting) are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on FSD Pharma Inc - Class B - Class B (Sub Voting)

The following chart shows the employed capital evolution of the two momentum strategies on FSD Pharma Inc - Class B - Class B (Sub Voting) since the beginning:

FSD Pharma Inc - Class B - Class B (Sub Voting)

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on FSD Pharma Inc - Class B - Class B (Sub Voting)

Buy the dip entry openings on FSD Pharma Inc - Class B - Class B (Sub Voting)

FSD Pharma Inc - Class B - Class B (Sub Voting)

The performance achieved by the robo-advisor on FSD Pharma Inc - Class B - Class B (Sub Voting) is 7.75%. That represents 19.36$ of latent gain with 249.92$ of employed capital. The following chart shows FSD Pharma Inc - Class B - Class B (Sub Voting) stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of FSD Pharma Inc - Class B - Class B (Sub Voting), and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

7.75 %

Latent gain

19.36 $

Invested capital

249.92 $

Annualized return

5.1 %

Equity curve of the strategy applied to FSD Pharma Inc - Class B - Class B (Sub Voting)

The following chart shows the result of the investment strategy applied to FSD Pharma Inc - Class B - Class B (Sub Voting):

FSD Pharma Inc - Class B - Class B (Sub Voting)

Note: the dividends potentially given by FSD Pharma Inc - Class B - Class B (Sub Voting) are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on FSD Pharma Inc - Class B - Class B (Sub Voting)

The following chart shows the employed capital evolution since the beginning of the investment strategy on FSD Pharma Inc - Class B - Class B (Sub Voting):

FSD Pharma Inc - Class B - Class B (Sub Voting)

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on FSD Pharma Inc - Class B - Class B (Sub Voting)

In this section, I will compare the three previous investment strategies applied to FSD Pharma Inc - Class B - Class B (Sub Voting).

Equity curve comparison on FSD Pharma Inc - Class B - Class B (Sub Voting)

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

FSD Pharma Inc - Class B - Class B (Sub Voting) investment strategy comparison

Employed capital comparison on FSD Pharma Inc - Class B - Class B (Sub Voting)

FSD Pharma Inc - Class B - Class B (Sub Voting) investment comparison

Performance comparison on FSD Pharma Inc - Class B - Class B (Sub Voting)

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 97.59% 1462.95$ 1499.13$ 27.72%
Momentum 1 quarter 456.17% 14824.16$ 3249.73$ 139.08%
Momentum 2 quarters 530.04% 13241.01$ 2498.1$ 174.36%
Non-directional 7.75% 19.36$ 249.92$ 5.1%
Annualized return comparison

Automatic investment

27.72 %

Momentum 1Q

174.36 %

Momentum 2Q

174.36 %

Non-directional

5.1 %

Correlated stocks

Here are the most positively and negatively correlated stocks with FSD Pharma Inc - Class B - Class B (Sub Voting):

Positive correlations

Most correlated stocks this year

  • FSD Pharma Inc - Class B - Class B (Sub Voting)

  • Most correlated stocks last 3 months

  • FSD Pharma Inc - Class B - Class B (Sub Voting)

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • Blue Apron Holdings Inc - Class A

  • Note: The algorithm computes the probability of correlation between FSD Pharma Inc - Class B - Class B (Sub Voting) and the other stocks. There may be false positives or some missing correlated stocks. If the price of FSD Pharma Inc - Class B - Class B (Sub Voting) does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name FSD Pharma Inc - Class B - Class B (Sub Voting)
    Country Canada
    City Toronto
    Address 199 Bay Street
    Phone
    Website www.fsdpharma.com
    FullTime employees 10
    Industry Drug Manufacturers—Specialty & Generic
    Sector Healthcare
    Exchange XNAS
    Ticker HUGE
    Market www.nasdaq.com

    FSD Pharma Inc - Class B - Class B (Sub Voting) ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown